Today: 9 June 2026
Verizon Just Broke a 13-Year Q1 Subscriber Slump. Here’s What Changed
28 April 2026
2 mins read

Verizon Just Broke a 13-Year Q1 Subscriber Slump. Here’s What Changed

New York—April 28, 2026, 08:01 EDT

Verizon Communications bumped its 2026 adjusted earnings-per-share outlook higher, citing an addition of 55,000 postpaid phone customers in the first quarter—a March-quarter uptick not seen since 2013. For new CEO Dan Schulman, that’s an early check mark. Adjusted EPS strips out specific items to show underlying profit per share.

This is notable since postpaid phone customers, who get billed monthly after using their service, form the backbone of the U.S. wireless sector. These subscribers typically shell out more and aren’t quick to jump ship, so even a small net increase counts in a quarter when phone signups usually lag.

Shares traded at $47.10 ahead of Tuesday’s U.S. open, up 69 cents, or roughly 1.5% from the prior close. Traders shrugged off the revenue shortfall, zeroing in on subscriber gains, shrinking churn, and a raised profit outlook.

Verizon reported a 2.9% increase in first-quarter revenue, totaling $34.4 billion. Net income edged up to $5.1 billion, a 3.3% gain. Adjusted earnings per share came in at $1.28, up 7.6%. Adjusted EBITDA landed at $13.4 billion, with $3.8 billion generated in free cash flow.

Schulman called the “turnaround” a story that’s “gaining momentum.” Verizon bumped up its full-year adjusted EPS forecast, now expecting $4.95 to $4.99 instead of the previous $4.90 to $4.95. The company also said it sees retail postpaid phone net adds coming in toward the higher end of its 750,000 to 1 million projection. Verizon

It comes down to basics: cut defections, lower the cost to snag new customers, push margins higher. Schulman, speaking to investors, called churn—customer turnover—“the clearest measure” of Verizon’s progress. Consumer postpaid phone churn landed at 0.90% for the quarter, dipping under 0.85% in March, according to Fortune. Fortune

Verizon CFO Tony Skiadas told MarketWatch the company can “attract customers with better economics” and doesn’t have to lean on “expensive promotions and free phones.” Over at Morningstar, Equity Director Michael Hodel sounded a more cautious note, pointing out that wireless churn is still high, though he conceded Verizon is “doing a much better job attracting new customers than a year ago.” MarketWatch

Competition remains fierce. AT&T brought in 294,000 postpaid phone subscribers in the first quarter, topping what analysts had penciled in. T-Mobile US was set to report after Tuesday’s close; the Street had pegged net postpaid phone adds at 393,100. Both AT&T and T-Mobile continue to lean on handset subsidies and service bundles to attract new customers.

Verizon leaned on its broadband business again, pulling in 341,000 new broadband subscribers for the quarter. Of those, 214,000 signed up for fixed wireless access, while 127,000 went with fiber. The Frontier Communications deal, which just wrapped up, bolstered the company’s fiber offering—now bundled with wireless plans.

The quarter had its blemishes. Revenue came in at $34.4 billion, falling short of the $34.84 billion LSEG consensus, according to Reuters. Wireless service revenue took a hit from credits linked to the January outage. Fixed wireless broadband subscriber gains lagged certain forecasts, and Verizon’s debt climbed after folding Frontier into the numbers.

Now comes the question: can Verizon resist jumping back into expensive promotions? Schulman, for one quarter, has handed investors firmer numbers to follow—positive phone additions, a dip in churn, acquisition costs down, and a bump to the EPS outlook.

Stock Market Today

  • J.M. Smucker Shares Rise After Earnings Beat Despite Sales Warning
    June 9, 2026, 10:05 AM EDT. J.M. Smucker shares rose 3.16% in pre-market trading after the company reported a 20% rise in adjusted earnings per share to $2.77, beating Wall Street estimates. The packaged-food firm grew net sales by 6% to $2.27 billion in Q4 but issued a cautionary note, forecasting a 3-4% decline in annual sales for fiscal 2027, below analysts' expectations of 1% growth. CEO Mark Smucker highlighted a focus on organic volume growth and profit improvement amid shifts in industry pricing strategies. Coffee sales drove quarterly results with a 12% retail sales increase but volume declines. The company flagged risks including consumer shifts to store brands, weight-loss drug impacts, and tariff fluctuations. Smucker's outlook balances lower sales with improved profitability.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
John Deere’s 300-Job U.S. Expansion Faces the Layoff Math Behind Its Comeback
Previous Story

John Deere’s 300-Job U.S. Expansion Faces the Layoff Math Behind Its Comeback

UAE Leaves OPEC: The May 1 Move That Could Rewire Oil Prices and Saudi Influence
Next Story

UAE Leaves OPEC: The May 1 Move That Could Rewire Oil Prices and Saudi Influence

Go toTop